Every breath of air, every strand of DNA and every cell in my body carries a chemical story that began long before Earth ...

Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...

Merhi reportedly explained a procedure still considered experimental: an injection of platelet-rich plasma, or PRP, into the ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 11, 2025 /PRNewswire/ -- Equity Insider News Commentary – November's wave of FDA oncology ...

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

The International Society for Stem Cell Research (ISSCR) today opened its sold-out international symposium, Accelerating ...

Dyne Therapeutics, citing trial data, said it will ask the FDA to approve DYNE-251, its therapy for DMD amenable to exon 51 skipping.

By setting up both reactions side by side in a test tube, the team revealed a literal tug-of-war between two DNA-repair pathways acting on the same HTT repeat. Which side wins likely determines ...

Multiple teams have used powerful imaging, targeted placebo experiments, and AI to map and understand the brainstem’s pain ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell ...

HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 ...